Work

Epacadostat plus pembrolizumab in patients with advanced urothelial carcinoma: Preliminary phase I/II results of ECHO-202/KEYNOTE-037.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.4503

Authors: David C. Smith, Thomas Gajewski, Omid Hamid, Jeffrey S. Wasser, Anthony J. Olszanski, Sandip P. Patel, Ronac Mamtani, Emmett V. Schmidt, Yufan Zhao, Janet E. Maleski, Tara C. Gangadhar

Institutions: University of Michigan, University of Chicago Medical Center, Angeles Clinic and Research Institute, UConn Health, Fox Chase Cancer Center, Moores Cancer Center, Abramson Cancer Center, Merck & Co., Inc., Rahway, NJ, USA (United States), Incyte (United States)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2758413282

Cites:

Cited by: 63

Related to: 10